Tuberculosis

The Bangladesh New Nation reports that new tuberculosis vaccines are promising but need to be researched far more before they become available to the public.

Tuberculosis

Pharmaceutical giant Archivel Farma has announced that it is considering a new theory about tuberculosis and is taking steps to combat the disease, which has caused two million deaths in the past year.

Tuberculosis

Greater than nine out of ten cases of tuberculosis could be avoided by 2050 through better testing, medicine and vaccines, according to a recently published review in the medical journal The Lancet.

TB

Mycobacterium tuberculosis (Mtb) possesses extraordinary survival ability by masking itself from the host immune system and persisting for decades inside the host.

Tuberculosis

Tuberculosis rates in the United States dropped more than 10 percent last year compared with 2008, the sharpest decrease ever recorded in a single year, the Centers for Disease Control and Prevention reported March 31.

Dr. Stephen Lockhart

When researchers at Oxford University took their development of a vaccine candidate against tuberculosis as far as they could, they found a commercial partner in Emergent BioSolutions.

Tevi Troy

There is relatively little interest about tuberculosis in the United States because there is a perception that this is just a developing world issue, says Tevi Troy, a writer and consultant on health care and domestic policy

Dr. Helen McShane

Although tuberculosis remains a global threat and a strengthening foe, the most effective vaccine against it is more than 80 years old.

This year's World TB Day theme, "On the move against tuberculosis: Innovate to accelerate action," addresses a critical aspect of the core business and values of the European & Developing Countries Clinical Trials Partnership.

World TB Day is March 24. This annual event commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacteria that cause tuberculosis.

Tuberculosis

In remarks March 24, World Tuberculosis Day, Secretary of State Hillary Rodham Clinton urged everyone to "reaffirm our commitment to tackle this deadly disease together."

On March 24, Aeras Global TB Vaccine Foundation recommitted itself to developing new and better TB vaccines and observed World TB Day 2010 by participating in events on three continents, the group said in a press release.

TB

Even with tuberculosis cases falling sharply in the United States to historic lows, strains of drug-resistant disease are gaining ground elsewhere in the world, the Centers for Disease Control Prevention and the World Health Organization report.

Tuberculosis

A booster shot has shown promise in improving tuberculosis resistance in previously vaccinated adults, according to new research in South Africa.

LONDON — An investigation is under way after a newborn baby was given 10 times the normal dose of a tuberculosis vaccine at a hospital in North Lincolnshire, England.

National Institute of Allergy and Infectious Diseases

A vaccine could cut tuberculosis cases among HIV-positive Africans by almost two-fifths, a U.S. study suggests.

TB

Public health officials are concerned about the implications of the first U.S. case of extremely drug-resistant tuberculosis, diagnosed in a 19-year-old Peruvian who is visiting here to study English, Homeland Security Today reported Dec. 29.

TB

The number of people developing tuberculosis continues to increase despite earlier signs of stabilizing, according to a report released Dec. 2 by the United Kingdom’s Health Protection Agency.

TB

National Health Service efforts to tackle tuberculosis in England are improving, but worryingly nearly 18 percent TB hot spot areas, and 60 percent of all areas, still don't have a strategy in place to tackle the disease.

SAN DIEGO — Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases — tuberculosis, malaria and dengue virus.

TB

Health experts will in the coming weeks converge in Mayuge and Iganga districts for a clinical trial, to test the world's first experimental tuberculosis vaccine in nearly a century, allAfrica.com reported Dec. 9.

Tuberculosis

CANCUN, Mexico — Health experts called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around the world last year.

Dr. Anthony Fauci

Dr. Anthony Fauci wrote this commentary, posted Nov. 17, for msnbc.com. He is director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.

Fuad El-Hibri

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced that it has completed the acquisition of a 55,000-square-foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the city of Baltimore.

With all the attention on H1N1 and the seasonal flu, it might be easy to forget about other infectious diseases.

The Oxford-Emergent Tuberculosis Consortium Ltd. has signed an agreement with Vivalis to evaluate large-scale commercial production capabilities for MVA85A, the consortium’s new TB vaccine candidate.

Tuberculosis

OXFORD, United Kingdom; ROCKVILLE, Md.; and NANTES, France — The Oxford-Emergent Tuberculosis Consortium Ltd., announced the signing of a commercial license agreement with Vivalis to evaluate large-scale commercial production capabilities for MVA85A.

Fuad El-Hibri

OXFORD, United Kingdom; ROCKVILLE, Md.; and BERLIN — The Oxford-Emergent Tuberculosis Consortium Ltd. announced the signing of a commercial license agreement with ProBioGen, to evaluate large-scale commercial production capabilities for MVA85A.

TB

The Aeras Global TB Vaccine Foundation, the Oxford-Emergent Tuberculosis Consortium Ltd., Isis Innovation Ltd., the Wellcome Trust and the University of Cape Town announce the start of a Phase IIb proof-of-concept clinical trial of a new TB vaccine.

TB

The University of Oxford and Emergent BioSolutions Inc. announced July 23, 2008, that they have formed the Oxford-Emergent Tuberculosis Consortium Ltd. to further develop MVA85A, a vaccine candidate for the prevention of tuberculosis.